Quality of life in individuals newly diagnosed with multiple sclerosis or clinically isolated syndrome

被引:2
|
作者
Alschuler, Kevin N. [1 ,2 ,6 ]
Whibley, Daniel [3 ,4 ]
Kratz, Anna L. [3 ]
Jensen, Mark P. [1 ]
Wundes, Annette [1 ,2 ]
von Geldern, Gloria [1 ,2 ]
Qian, Peiqing [5 ]
Bombardier, Charles H. [1 ]
Ehde, Dawn M. [1 ]
机构
[1] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[3] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA
[4] Univ Aberdeen, Sch Med Med Sci & Nutr, Epidemiol Grp, Aberdeen, Scotland
[5] Swedish Neurosci Inst, Seattle, WA USA
[6] Univ Washington, 1536 N 115th St,Box 358815, Seattle, WA 98133 USA
关键词
Multiple sclerosis; Quality of life; New diagnosis; Coping; Adjustment; COGNITIVE IMPAIRMENT; FOLLOW-UP; SCALE; VALIDATION; DEPRESSION; QUESTIONNAIRE; DISABILITY; DISTRESS; VALIDITY; ANXIETY;
D O I
10.1007/s00415-021-10842-w
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Little is known about quality of life (QOL) at the time of multiple sclerosis (MS) or clinically isolated syndrome (CIS) diagnosis and how it evolves in the critical adjustment period immediately following a new diagnosis. Objectives To (1) describe QOL trajectory in the first year post-MS/CIS diagnosis and (2) examine associations of demographic and biopsychosocial factors with QOL at baseline and as it evolves over the first year post-MS/CIS diagnosis. Methods Participants were N = 250 individuals newly diagnosed with MS or CIS. Participants completed self-report assessments of QOL, demographics, and biopsychosocial factors at 1, 2, 3, 6, 9, and 12 months post-diagnosis using validated measures. Results At 1-month post-diagnosis, QOL M = 75.2/100 with subsequent assessments revealing consistent ratings on average. Modelling revealed a small number of variables that were predictive of QOL at baseline and/or change in QOL over time. Conclusion QOL in the first year post-MS/CIS diagnosis was, on average, high and stable. A subset of modifiable factors across the biopsychosocial spectrum was associated with baseline level of QOL and change in QOL over time. The stability in QOL suggests that patients can be assessed early after diagnosis for key variables that are predictive of both current and future QOL.
引用
收藏
页码:2560 / 2572
页数:13
相关论文
共 50 条
  • [21] Quality of life in patients with clinically isolated syndromes or multiple sclerosis: the impact of diagnosis disclosure
    Milani, P.
    Balugani, R.
    D'Alessandro, R.
    Galeotti, M.
    Guerrini, C.
    Lugaresi, C.
    Matarozzi, K.
    Vignatelli, L.
    Tola, M. R.
    MULTIPLE SCLEROSIS, 2007, 13 : S262 - S262
  • [22] Fatigue, depression and quality of life in patients with clinically isolated syndrome and early multiple sclerosis: results from the BEGIN study
    Penner, I. K.
    Tintore, M.
    Daumer, M.
    Hagstromer, M.
    Sjostrom, M.
    Wicklein, E. M.
    JOURNAL OF NEUROLOGY, 2011, 258 : 263 - 263
  • [23] The Comparison of Physical Activity Status, Exercise Perception and Quality of Life Between Clinically Isolated Syndrome and Multiple Sclerosis Patients
    Ertekin, Ozge
    Ozakbas, Serkan
    Cinar, Bilge Piri
    Algun, Z. Candan
    Idiman, Egemen
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2013, 50 (02): : 116 - 121
  • [24] Fampridine and quality of life in individuals with multiple sclerosis
    Sagawa, Yoshimasa, Jr.
    Magnin, Eloi
    Paillot, Laura
    Moulin, Thierry
    Decavel, Pierre
    SPRINGERPLUS, 2016, 5
  • [25] Influence of cognitive dysfunctions, fatigue and depression on quality of life in newly diagnosed multiple sclerosis patients
    Engel, C
    Greim, B
    Zettl, UK
    MULTIPLE SCLEROSIS, 2005, 11 : S90 - S91
  • [26] Predictive factors of conversion of clinically isolated syndrome to clinically definite multiple sclerosis
    Kolcava, J.
    Vlckova, E.
    Pelisek, O.
    Kocica, J.
    Krkoska, P.
    Bednarik, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 640 - 641
  • [27] Clinically isolated syndrome: diagnosis and risk of developing clinically definite multiple sclerosis
    Lopez-Gomez, J.
    Sacristan-Enciso, B.
    Caro-Miro, M. A.
    Pascual, M. R. Querol
    NEUROLOGIA, 2023, 38 (09): : 663 - 670
  • [28] Anxiety and depressive symptoms in clinically isolated syndrome and multiple sclerosis
    Anhoque, Carolina Fiorin
    Aires Domingues, Simone Cristina
    Carvalho, Thiago
    Teixeira, Antonio Lucio
    Domingues, Renan Barros
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2011, 69 (06) : 882 - 886
  • [29] Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis Reply
    Metz, Luanne M.
    Eliasziw, Misha
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (08): : 789 - 789
  • [30] Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis
    Crnosija, L.
    Adamec, I.
    Lovric, M.
    Junakovic, A.
    Skoric, M. Krbot
    Habek, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E199 - E199